Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Jul;46(7):678–680. doi: 10.1136/jcp.46.7.678

Waldenström's macroglobulinaemia secreting a paraprotein with lupus anticoagulant activity: possible association with gastrointestinal tract disease and malabsorption.

R C Tait 1, P K Oogarah 1, J B Houghton 1, S E Farrand 1, M R Haeney 1
PMCID: PMC501404  PMID: 8157762

Abstract

A 51 year old man with Waldenström's macroglobulinaemia presented with a malabsorptive syndrome related to extensive small bowel lymphangiectasia caused by immunoglobulin accumulation. The patient's plasma had strong lupus anticoagulant activity and the IgM lambda paraprotein displayed specificity for the negatively charged phospholipids phosphatidyl serine and phosphatidyl inositol, as well as the neutral phosphatidic acid. Despite treatment for the macroglobulinaemia the patient died and at necropsy was found to have myocardial ischaemia and segmental infarcts in the spleen and kidney. The coexistence of these relatively rare findings suggests a possible association between Waldenström's macroglobulinaemia with gastrointestinal manifestations and paraprotein specificity for phospholipid.

Full text

PDF
678

Images in this article

678Image
on p.678
679Image
on p.679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedine M. S., Yardley J. H., Elliott H. L., Banwell J. G., Hendrix T. R. Intestinal involvement in Waldenstrom's macroglobulinemia. Gastroenterology. 1973 Aug;65(2):308–315. [PubMed] [Google Scholar]
  2. Bellotti V., Gamba G., Merlini G., Montani N., Bucciarelli E., Stoppini M., Ascari E. Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants. Br J Haematol. 1989 Oct;73(2):221–227. doi: 10.1111/j.1365-2141.1989.tb00256.x. [DOI] [PubMed] [Google Scholar]
  3. CABRERA A., DELAPAVA S., PICKREN J. W. INTESTINAL LOCALIZATION OF WALDENSTROM'S DISEASE. Arch Intern Med. 1964 Sep;114:399–407. doi: 10.1001/archinte.1964.03860090133014. [DOI] [PubMed] [Google Scholar]
  4. Cooper M. R., Cohen H. J., Huntley C. C., Waite B. M., Spees L., Spurr C. L. A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma. Blood. 1974 Apr;43(4):493–504. [PubMed] [Google Scholar]
  5. Gastineau D. A., Kazmier F. J., Nichols W. L., Bowie E. J. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985 Jul;19(3):265–275. doi: 10.1002/ajh.2830190308. [DOI] [PubMed] [Google Scholar]
  6. Harris M., Burton I. E., Scarffe J. H. Macroglobulinaemia and intestinal lymphangiectasia: a rare association. J Clin Pathol. 1983 Jan;36(1):30–36. doi: 10.1136/jcp.36.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pruzanski W., Warren R. E., Goldie J. H., Katz A. Malabsorption syndrome with infiltration of the intestinal wall by extracellular monoclonal macroglobulin. Am J Med. 1973 Jun;54(6):811–818. doi: 10.1016/0002-9343(73)90070-3. [DOI] [PubMed] [Google Scholar]
  8. Thiagarajan P., Shapiro S. S., De Marco L. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest. 1980 Sep;66(3):397–405. doi: 10.1172/JCI109869. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES